Cargando…

Crystal structure of bis­[di­hydro­bis­(pyrazol-1-yl)borato-κ(2) N (2),N (2′)](1,10-phenanthroline-κ(2) N,N′)zinc(II)

The asymmetric unit of the title compound, [Zn(C(6)H(8)N(4)B)(2)(C(12)H(8)N(2))], comprises one half of a Zn(II) cation (site symmetry 2), one di­hydro­bis­(pyrazol-1-yl)borate ligand in a general position, and one half of a phenanthroline ligand, the other half being completed by twofold rotation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ossinger, Sascha, Näther, Christian, Tuczek, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690474/
https://www.ncbi.nlm.nih.gov/pubmed/31417775
http://dx.doi.org/10.1107/S2056989019009289
Descripción
Sumario:The asymmetric unit of the title compound, [Zn(C(6)H(8)N(4)B)(2)(C(12)H(8)N(2))], comprises one half of a Zn(II) cation (site symmetry 2), one di­hydro­bis­(pyrazol-1-yl)borate ligand in a general position, and one half of a phenanthroline ligand, the other half being completed by twofold rotation symmetry. The Zn(II) cation is coordinated in form of a slightly distorted octa­hedron by the N atoms of a phenanthroline ligand and by two pairs of N atoms of symmetry-related di­hydro­bis­(pyrazol-1-yl)borate ligands. The discrete complexes are arranged into columns that elongate in the c-axis direction with a parallel alignment of the phenanthroline ligands, indicating weak π–π inter­actions.